Navigation Links
GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
Date:1/21/2013

Austin, Texas (PRWEB) January 21, 2013

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, GranuFlo Recall Help (http://www.granuflorecallhelp.com/). The site will serve as a source for news and legal information for patients and their families who have experienced side effects after receiving hemodialysis treatment with GranuFlo or NaturaLyte dialysate concentrates.

The Food and Drug Administration (FDA) issued a Class 1 Recall of GranuFlo dry acid concentrate and NaturaLyte liquid acid concentrate in March 2012 after it was presented with a leaked internal memo from GranuFlo and NaturaLyte manufacturer Fresenius Medical Care (FMC).

GranuFlo and NaturaLyte acid concentrates contain bicarbonate, which is used during hemodialysis treatment to neutralize acid build up in the blood. When patients have elevated pre-dialysis bicarbonate blood levels, the addition of GranuFlo or NaturaLyte could raise bicarbonate levels to dangerous heights, resulting in serious side effects such as heart attack, stroke or sudden death.

In their November 2011 internal memo, Fresenius Medical Care warned that patients with elevated bicarbonate levels were six times more likely to suffer a heart attack or sudden cardiac death from GranuFlo or NaturaLyte than patients using other dialysis products. Fresenius also reported that 941 patients had experienced sudden cardiac arrest within their dialysis clinics in 2010 after undergoing hemodialysis treatment with GranuFlo or NaturaLyte.

According to The New York Times, Fresenius Medical Care issued this memo to dialysis centers owned by Fresenius, but did not warn thousands of non-Fresenius owned dialysis clinics using GranuFlo and NaturaLyte products until March 2012.

Patients who have experienced heart attack, stroke, or other injuries after being treated with GranuFlo or NaturaLyte may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com

About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents individuals affected by the side effects of GranuFlo and NaturaLyte, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa, Paxil and Effexor, problems with transvaginal mesh, DePuy ASR and Pinnacle hip replacements, Actos bladder cancer, birth defects caused by Topamax and other defective drugs and medical devices.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10322291.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
2. Digital breast tomosynthesis cuts recall rates by 40 percent
3. Graphic warning labels improve smokers recall of warning and health risks related to smoking
4. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
5. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
6. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
7. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
8. US Drug Watchdog Dramatically Increases Their Efforts To Get All Recalled DePuy ASR Hip Implant Recipients Identified To The Best Possible Attorneys Before Time Runs Out
9. US Drug Watchdog Now Offers To Help All Recalled DePuy ASR Hip Implant Recipients Get To The Best Attorneys Out Of Fear These Recipients Won't Be Compensated
10. The US Drug Watchdog Now Offers To Help All Recipients Of Recalled DePuy ASR Hip Implant Get To The Best Attorneys Because Time Could Run Out To Get Them Identified
11. Imported Ricotta Cheese Recalled Due to Listeria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... January 20, 2017 , ... Today, the Centers for Medicare & Medicaid Services ... Alternative Payment Models (APMs) in 2017. Clinicians who participate in APMs are paid for ... part of the Administration’s effort to build a system that delivers better care and ...
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, the ... Congressional political games that circumvent health needs of over 30 million. Many interviews with ... anxieties and needs government public servants were suppose to prioritize. Interviews provided below. ...
(Date:1/19/2017)... ... January 19, 2017 , ... With the cold weather here, many people will have ... are efficient when clearing large amounts of snow, but they can be dangerous when used ... Consumer Product Safety Commission for the proper use of snow blowers:, , ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... ... for Leading Companies – our new study reveals trends, ... issues and events affecting the Alzheimer,s disease therapeutics and ... answer these key questions: - How is the Alzheimer,s ...
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... , January 19, 2017 ... ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... Published recently in a ... peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: